Pharvaris (PHVS) Receivables (2019 - 2026)

Pharvaris (PHVS) has 8 years of Receivables data on file, last reported at $1.1 million in Q1 2026.

• Quarterly Receivables rose 85.07% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 85.07% YoY) and the FY2025 annual result came in at $5.1 million, up 61.34% from the prior year.
• Receivables climbed to $1.1 million in Q1 2026, from $648068.4 in the prior quarter.
• In the past five years, Receivables ranged from a high of $2.9 million in Q2 2025 to a low of $336205.7 in Q3 2023.
• A 5-year average of $759086.4 and a median of $472442.4 in 2023 frame the typical range for Receivables.
• Annual changes were most pronounced in 2022 — Receivables tumbled 58.74% — and 2024, when it soared 376.55%.
• Tracing PHVS's Receivables over 5 years: stood at $390212.0 in 2022, then grew by 16.77% to $455645.5 in 2023, then rose by 7.37% to $489239.3 in 2024, then soared by 32.46% to $648068.4 in 2025, then soared by 75.16% to $1.1 million in 2026.
• The last three Receivables figures came in at $1.1 million (Q1 2026), $648068.4 (Q4 2025), and $2.9 million (Q2 2025), per Business Quant data.